Skip to main content

What the FDA labels say about taking them together

Cabergoline and metoclopramide

Cabergoline's FDA label of June 30, 2026 names metoclopramide in its drug interactions section, and metoclopramide's label names cabergoline too. The cabergoline label: “DRUG INTERACTIONS CABERGOLINE, a dopamine receptor agonist, is not recommended for concomitant use with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthenes, or metoclopramide.”

Check it at the source: the cabergoline FDA label on DailyMed (effective June 30, 2026, Mylan Pharmaceuticals Inc.); the metoclopramide FDA label on DailyMed (effective May 18, 2026, ANI Pharmaceuticals, Inc.).

What does the cabergoline label say about metoclopramide?

Cabergoline label, drug interactions

DRUG INTERACTIONS CABERGOLINE, a dopamine receptor agonist, is not recommended for concomitant use with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthenes, or metoclopramide.

Source: FDA drug label (Cabergoline), NDA020664 (Pfizer), as published by Mylan Pharmaceuticals Inc., effective June 30, 2026 (SPL set e497366b-a124-4d7f-bd45-a883c392d4bb), via openFDA; the full label on DailyMed

What does the metoclopramide label say about cabergoline?

Metoclopramide label, drug interactions

Examples; apomorphine, bromocriptine, cabergoline, levodopa, pramipexole, ropinirole, and rotigotine

Source: FDA drug label (Metoclopramide), NDA017854 (Ani Pharms), as published by ANI Pharmaceuticals, Inc., effective May 18, 2026 (SPL set 797aad80-0597-42f8-99d5-39de180c3b5a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

8Cabergoline generic labelers
39Metoclopramide generic labelers
CabergolineMetoclopramide
Labeled forn/aAcid reflux and ulcers, Nausea and vomiting
Boxed warningNoYes
Pharmacy cost (NADAC)$1.30 per tablet 0.5 mg tablet$0.0439 per tablet 10 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?